Track marks are the most recognized physical skin finding that indicates opioid abuse. These linear rows of small puncture wounds appear along veins, most commonly on the inner arm near the elbow crease (the antecubital fossa). But track marks are only one of several skin changes associated with opioid use, and the full picture includes injection scars, infections, itching-related damage, vein changes, and newer findings linked to contaminated drug supplies.
Track Marks and What They Look Like
Track marks are closely spaced needle punctures that follow the path of a vein, appearing as small black dots arranged in a line. The surrounding skin often looks darkened due to post-inflammatory pigment changes from repeated irritation. In active users, the area around the marks may be red, swollen, or firm to the touch, which reflects inflammation from the drug leaking into surrounding tissue or from early infection. Over time, the underlying vein becomes scarred and hard, a process called venous sclerosis caused by repeated chemical irritation triggering localized clot formation and fibrosis.
In a study of injection drug users at a treatment center in Northern India, 92 out of the total patients examined had visible track marks, making them the single most common skin finding. They are considered one of the most reliable physical signs of active injection drug use.
As superficial veins on the inner arms become damaged and lose blood flow, users often move to less obvious injection sites: the hands, feet, neck, groin, or legs. Finding track marks in these unusual locations often signals longer-duration use, because the more accessible veins have already been destroyed.
Skin Popping Scars
Not all opioid injection goes into veins. “Skin popping” means injecting directly into or just beneath the skin for slower drug absorption. This produces a distinctly different pattern: round, depressed, pitted scars typically 5 to 15 millimeters across, often with darkened pigmentation. In one documented case, a patient had 40 to 60 of these hyperpigmented, fibrotic, sunken papules scattered across her forearms and lower legs, discovered incidentally during a routine dermatology visit.
Skin popping initially creates small, deep, punched-out ulcers. These heal slowly and often become infected before they scar over. The resulting scars are permanent and quite distinctive: clustered round depressions that don’t match the pattern of any common skin disease. In people prone to raised scarring, the same process can produce thick, nodular keloids instead of depressed pits. Chronic skin popping can also cause granulomas, which are small firm lumps that form when the body walls off contaminants like talc or other cutting agents mixed into the drug.
Injection-Related Infections
Skin infections are extremely common among people who inject opioids. About one-third of people who inject drugs in the United Kingdom report symptoms of an injection-site infection within the previous year. When these infections lead to hospitalization, the breakdown looks like this: cutaneous abscesses account for roughly 35% of admissions, vein inflammation (phlebitis) for 32%, and cellulitis for 23%. More dangerous complications like blood infections, bone infections, heart valve infections, and necrotizing fasciitis make up the remaining cases.
On the skin, these infections appear as warm, red, swollen areas around injection sites. Abscesses form painful, pus-filled lumps. Cellulitis spreads as a widening area of redness and heat, sometimes with visible streaking along the lymphatic channels. These findings tend to recur in the same areas where someone regularly injects, which helps distinguish them from infections with other causes.
Xylazine Wounds
A newer and increasingly common skin finding is linked to xylazine, a veterinary sedative now frequently mixed into illicit fentanyl supplies. Xylazine-associated wounds look different from typical injection-related infections. They present as areas of purplish, net-like discoloration that progress to frank skin death and deep, slow-healing ulcers. These necrotic wounds appear at and sometimes far from injection sites.
The likely mechanism is local blood vessel constriction. Xylazine acts on receptors that tighten small blood vessels, cutting off blood flow to the skin and making it vulnerable to tissue death and secondary infection. On biopsy, the tissue shows dying skin with tiny clots in the small blood vessels but no true vessel inflammation. These wounds have become a hallmark of the current fentanyl supply in many U.S. cities, and their presence on a patient’s skin is a strong indicator of recent illicit opioid use.
Opioid-Induced Itching and Scratch Marks
Opioids cause itching through two separate pathways. In the skin, opioids trigger certain immune cells to release histamine, which activates itch-sensing nerve fibers. In the spinal cord, opioids suppress the chemical signals that normally keep itching in check, essentially turning up the itch volume from the inside. This means opioid-induced itching is both a surface reaction and a nervous system effect, which is why it can be intense and widespread rather than limited to one spot.
The visible result is excoriations: linear scratch marks, raw patches, and picked-at skin, often concentrated on the face, nose, arms, and chest. In chronic users, repeated scratching causes thickened, darkened skin and scabbed areas that never fully heal before being scratched open again. These findings aren’t specific to opioids on their own, but combined with other signs, they add to the overall clinical picture.
Vein Changes Visible Through the Skin
Long-term injection causes permanent changes to the veins themselves. Repeated puncture and exposure to irritating substances triggers fibrosis, turning once-soft veins into firm, cord-like structures you can feel (and sometimes see) beneath the skin. These hardened veins are sometimes called “roping” because they feel like a stiff rope running under the surface. Swelling and tenderness develop at valve sites within the vein, and over time the vein loses the ability to carry blood entirely.
On the forearms of long-term users, these sclerosed veins may be visible as darkened, raised, firm lines that no longer compress when pressed. This finding, in combination with overlying track marks, is highly characteristic of chronic injection drug use.
Gooseflesh During Withdrawal
One skin finding points not to active use but to withdrawal. Piloerection, commonly known as gooseflesh or goosebumps, is a recognized diagnostic criterion for opioid withdrawal in the DSM-5. It results from the nervous system becoming hyperactive once opioids are removed. The same brain region that opioids suppress during use rebounds sharply during withdrawal, producing a flood of adrenaline-like activity that causes the tiny muscles at each hair follicle to contract.
Gooseflesh during withdrawal is typically accompanied by sweating, dilated pupils, runny nose, and visible muscle twitching. The phrase “cold turkey” likely originates from the goosebumped, pale appearance of the skin during opioid withdrawal.
How These Signs Overlap With Other Conditions
No single skin finding proves opioid abuse in isolation. Track marks can sometimes be confused with repeated blood draws or insulin injection sites in diabetic patients. Excoriations from itching can result from many causes, including eczema, liver disease, or other medications. Abscesses and cellulitis occur in people who never use drugs.
What makes the pattern distinctive is the combination and location. Multiple round, depressed scars on the forearms and lower legs, hardened veins, darkened linear marks over venous paths, and recurrent soft tissue infections concentrated at common injection sites create a constellation that is difficult to attribute to anything else. Skin popping scars in particular have been described as “important clues for possible drug abuse” because their size, shape, distribution, and depressed texture don’t match common dermatological conditions.